Lupin Ltd Quarterly Results
Q2 FY25-26 Results Summary
Revenue
The revenue stands at ₹7,047.51 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.43 per cent from ₹6,268.34 crore. This corresponds to a year-on-year *(YoY) growth of 24.23 per cent.
Operating Profit
Operating Profit stands at ₹197.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.69 per cent from ₹170.80 crore. This corresponds to a year-on-year *(YoY) growth of 74.61 per cent.
PBDT
PBDT stands at ₹838.91 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.14 per cent from ₹493.06 crore. This corresponds to a year-on-year *(YoY) growth of 85.48 per cent.
Profit Before Tax
Profit Before Tax stands at ₹2,006.97 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.78 per cent from ₹1,415.54 crore. This corresponds to a year-on-year *(YoY) growth of 90.26 per cent.
Net Profit
Net Profit stands at ₹1,477.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,219.03 crore. This represents a 73.34 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Lupin Ltd News
Lupin Ltd Earnings
- YOY
- QOQ
Lupin Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Lupin Ltd Research Reports
Lupin Ltd Financial Reports
Lupin Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 3.80% | 2.31% | 3.89% | 12.92% | 11.98% | -4.46% |
| Torrent Pharma. | 1.59% | 2.31% | 4.75% | 10.36% | 18.45% | 18.39% |
| Cipla | 0.73% | 2.02% | 2.20% | 2.39% | 2.84% | 2.36% |
| Dr Reddy's Labs | 0.62% | 0.22% | -0.86% | 1.77% | -2.15% | -8.34% |
| Zydus Lifesci. | 1.07% | 1.90% | 0.81% | -5.51% | -5.21% | -5.06% |
| Mankind Pharma | 2.03% | 3.48% | 2.43% | -8.63% | -7.91% | -22.19% |
| Aurobindo Pharma | 2.47% | 3.45% | 4.87% | 15.34% | 7.54% | -3.72% |
Company Info
Company Information
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal
